Ethics approval and consent to participate
This study was approved by the ethics committee of Beijing Hospital (reference number: 2020BJYYEC-021–02). Our study is a post-hoc analysis of data from an IRB-approved prospective clinical trial (NCT03905200). Informed consent was obtained from all individual participants included in the study.